PITTSBURGH – SARS-CoV-2 nanobodies—microscopic molecules developed at the University of Pittsburgh School of Medicine that neutralize the virus in animals—are remarkably active against mutations found in invariants, including Delta, according to new research by Pitt and Case Western Reserve University scientists. The findings, announced today in Nature Communications, describe three different mechanisms by which the...
